Skip to main content

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Volume 11, Number 8, December 2012

Articles

Favourites:
ADD

Free Content Commentary (Research Highlights: Utilizing Neuro-Inflammation: Turning Degeneration to Regeneration)
pp. 953-954(2)
Authors: Cui, Ying; Li, Jiang; Arias-Carrion, Oscar; Yuan, Ti-Fei

Favourites:
ADD
Favourites:
ADD

C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets
pp. 957-964(8)
Authors: Vistbakka, Julia; VanDuyn, Natalia; Wong, Garry; Nass, Richard

Favourites:
ADD

Open Access Effects of α-Synuclein Overexpression in Transgenic Caenorhabditis elegans Strains
pp. 965-975(11)
Authors: Bodhicharla, Rakesh; Nagarajan, Archana; Winter, Jody; Adenle, Ademola; Nazir, Aamir; Brady, Declan; Vere, Kelly; Richens, Jo; O'Shea, Paul; R. Bell, David; de Pomerai, David

Favourites:
ADD

Iridoid Compound 10-O-trans-p-Coumaroylcatalpol Extends Longevity and Reduces Alpha Synuclein Aggregation in Caenorhabditis elegans
pp. 984-992(9)
Authors: Shukla, Virendra; C. Phulara, Suresh; Yadav, Deepti; Tiwari, Sudeep; Kaur, Supinder; M. Gupta, M.; Nazir, Aamir; Pandey, Rakesh

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

An Overview on Potential Neuroprotective Compounds for Management of Alzheimer's Disease
pp. 1006-1011(6)
Authors: Ahmed Sheikh, Ishfaq; Ali, Riyasat; A. Dar, Tanveer; Amjad Kamal, Mohammad

Favourites:
ADD

Nuclear Factor Erythroid 2 - Related Factor 2 Signaling in Parkinson Disease: A Promising Multi Therapeutic Target Against Oxidative Stress, Neuroinflammation and Cell Death
pp. 1015-1029(15)
Authors: Kumar, Hemant; Koppula, Sushruta; Kim, In-Su; Vasant More, Sandeep; Kim, Byung-Wook; Choi, Dong-Kug

Favourites:
ADD

The Protective Effects of Jatrorrhizine on β-Amyloid (25-35)-Induced Neurotoxicity in Rat Cortical Neurons
pp. 1030-1037(8)
Authors: Luo, Tao; Jiang, Wei; Kong, Yan; Li, Sheng; He, Feng; Xu, Jie; Wang, Hua-Qiao

Favourites:
ADD
Favourites:
ADD

Geniposide Regulates Insulin-Degrading Enzyme Expression to Inhibit the Cytotoxicity of Aβ1-42 in Cortical Neurons
pp. 1045-1051(7)
Authors: Yin, Fei; Zhang, Yonglan; Guo, Lixia; Kong, Shuzhen; Liu, Jianhui

Favourites:
ADD

Acetylcholinesterase Inhibitors as Pretreatment Before Acute Exposure to Organophosphates: Assessment Using Methyl-Paraoxon
pp. 1052-1060(9)
Authors: E. Lorke, Dietrich; Y. Hasan, Mohamed; M. Nurulain, Syed; Shafiullah, Mohamed; Kuca, Kamil; A. Petroianu, Georg

Favourites:
ADD

Restless Legs Syndrome in Multiple Sclerosis
pp. 1061-1069(9)
Authors: Zecca, Chiara; Manconi, Mauro; Fulda, Stephany; Gobbi, Claudio

Favourites:
ADD

Outcome-Dependent Global Similarity Analysis of Imbalanced Core Signaling Pathways in Ischemic Mouse Hippocampus
pp. 1070-1082(13)
Authors: Liu, Jun; Zhang, Zhan-jun; Zhou, Cai-xiu; Wang, Yi; Cheng, Yi-yu; Darrel Duan, Da-yue; Wang, Yong-yan; Wang, Zhong

Favourites:
ADD
Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more